J
Jose Barreau
3
APPEARANCES
3
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
Sep 2, 2026
Starting, Scaling, and Selling a Healthcare Startup with Dr. Jose Barreau
10:26
10:38

Alison CurfmanHOST
But I'd love to hear your thoughts on that because I think it's one of the number one things that prevents people from saying, I want to pursue starting a new venture.

Jose BarreauGUEST
Well, I mean, I think there's a couple of things there, right? So, you know, a lot of people have taken time to build up their practice.
6 MINS LATER
A New Category in Cancer Care, Built by the People Who Saw It Fail
35:06
35:14
35:19
35:52
35:59
35:00
But what's surprising you that we're conventional screening is just missing.

Jose BarreauGUEST
You know, it's so there, you know, there's going to be 2.1 million cases of cancer this year, right.

Jose BarreauGUEST
And, uh, and that excludes skin cancers, you know, basal cell squamous, all those types of things.

Jose BarreauGUEST
So I'm talking about cancers that could potentially be fatal and, you know, the incentives in medicine are not in prevention we know that across the board right we know that the incentives are in treating disease and the same could be said for oncology the incentive is to develop drugs that treat disease and the incentive is to improve those drugs right and keep the patient alive.

Jose BarreauGUEST
And not to be cynical in saying we're purposely trying to do that, but that's just the way the system is built.

Jose BarreauGUEST
And so if you look at how many drugs have been approved for oncology in the last 10 years, it's 500 plus.
40:28
Tell us a little bit about some of the success stories that you've had that probably multiple, we don't have time for it, but what's one or two that stand out for you?
A New Category in Cancer Care, Built by the People Who Saw It Fail
35:50
35:58
36:16
35:44
But what's surprising you that we're conventional screening is just missing.

Jose BarreauGUEST
you know, it's so there, you know, there's going to be 2.1 million cases of cancer this year, right.

Jose BarreauGUEST
And, and that excludes skin cancers, you know, basal cells, squamous, all those types of things.

Jose BarreauGUEST
We know that across the board, right? We know that the incentives are in treating disease.
41:12
Tell us a little bit about some of the success stories that you've had that probably multiple, we don't have time for it, but what's one or two that stand out for you?
